Combating counterfeit Rx from China

Jul 16, 2007

Agencies worldwide are cracking down on counterfeit pharmaceuticals, and much of the focus has been on China, where an official was recently executed for approving fake medicines. While most of these drugs reach consumers through online or illegal suppliers, there’s a growing threat to outlets considered more safe, like the neighborhood pharmacy, said Temple University pharmacoeconomist, Albert Wertheimer, Ph.D., who will talk about combating counterfeit pharmaceuticals coming out of China at a U.S. Patent and Trademark Office (USPTO) seminar on July 23 and 24 in Philadelphia.

Internet pharmacies, which are extremely difficult to monitor and regulate, pose the biggest threat, but counterfeits could soon make their way into mainstream channels via sophisticated fakery and old-fashioned bribery.

“Counterfeiters have gotten very good at replicating labels and packaging,” said Wertheimer, who will focus on techniques used in other fields to identify fake goods, as well as the importance of detecting counterfeits early in the supply chain.

“Governments and industry must realize that when the danger actually becomes visible, patients may already have suffered harm,” he said.

Global efforts are underway to develop an international database that documents all counterfeit drug activity. Experts also urge greater coordination with the pharmaceutical industry.

Additionally, officials are looking at effective strategies used in other fields to fight counterfeiting including a pedigree system, which would record the path of ownership and location of a drug shipment. Each purchaser along the supply chain would add information and verify authenticity. Another technique uses sensors, inert substances that can be added to a liquid or pill, that would verify authenticity. Officials could also borrow a strategy from the retail industry – radiofrequency identification, whereby drugs would be tagged similar to clothing items.

“Still, technology cannot be a permanent, foolproof solution, and only by improving importation and regulation policy can counterfeiting be contained further. The Food and Drug Administration's Counterfeit Drug Task Force believes that attacking the problem through multiple routes will be the most effective way to combat drug counterfeiting,” Wertheimer said.

In general, counterfeit means that a drug can lack an important ingredient, contain a harmful ingredient or be mislabeled. Some of the most commonly counterfeited drugs include those for erectile dysfunction, depression, anxiety and infection. In a recent study, the World Health Organization determined global sales of counterfeit drugs to be $32 billion in 2003 – 10 percent of all medicines sold worldwide.

“Drug counterfeiting is a threat that every nation faces and the activity is very difficult to identify, trace, and combat. The growth of online drug sales, counterfeiters' increasing technologic skill, and a false sense of security in countries with stringent regulatory measures are among the factors that are enabling the spread of this criminal activity,” Wertheimer said.

U.S. and Chinese speakers at the USPTO event will be drawn from the academic and governmental fields as well as industry. Conference attendees will include businesses and companies doing or contemplating doing business with or in China, as well as those who want to protect themselves against counterfeiting and piracy from China.

Source: Temple University

Explore further: Feds vows to publicize vaccine injury help program

add to favorites email to friend print save as pdf

Related Stories

Shaking up biomolecules with light

Sep 28, 2012

(Phys.org)—In living organisms, biomolecules such as proteins are constantly in complex motion, bending and flexing in different ways at different points. Each molecule has its own vibrational dynamics ...

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.